Therapeutic Asset Ratings
1,537 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Busulphan
Fucosidosis
Masonic Cancer Center, University of Minnesota
P2/3
BB
(67)
Busulphan
Globoid Cell Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2/3
BB
(67)
Busulphan
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2/3
BB
(67)
Cediranib
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
BB
(67)
Cyclophosphamide
Metastatic Cancer
InSilico Medicine Hong Kong Limited
P2/3
BB
(67)
Cyclophosphamide
Sickle Cell Disease
St. Jude Children's Research Hospital
P2/3
BB
(67)
DEXAMETHASONE
Recurrent Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P2/3
BB
(67)
Encorafenib
Metastatic Colon Adenocarcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
P2/3
BB
(67)
Epirubicin
Metastatic Cancer
InSilico Medicine Hong Kong Limited
P2/3
BB
(67)
Fampridine
Optic Neuritis
Courtney Casserly
P2/3
BB
(67)
Fludarabine
Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2/3
BB
(67)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2/3
BB
(67)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Severe Combined Immunodeficiency
Washington University School of Medicine
P2/3
BB
(67)
Inno-206
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Li Zhiming
P2/3
BB
(67)
Inno-206
Fallopian Tube High Grade Serous Adenocarcinoma
National Cancer Institute (NCI)
P2/3
BB
(67)
Inno-206
Intravascular Large B-Cell Lymphoma
Northwestern University
P2/3
BB
(67)
Inno-206
Mature B-Cell Lymphoma
BeOne Medicines
P2/3
BB
(67)
L-HUPERZINE A
Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD
P2/3
BB
(67)
LIDOCAINE
Cancer Pain
Instituto Nacional de Cancer, Brazil
P2/3
BB
(67)
LIDOCAINE
Cancer-related Pain
National and Kapodistrian University of Athens
P2/3
BB
(67)
mlc1501
Stroke, Ischemic
Moleac Pte Ltd.
P2/3
BB
(67)
mlc1501
Strokes Thrombotic
Moleac Pte Ltd.
P2/3
BB
(67)
Pembrolizumab
Metastatic Cancer
InSilico Medicine Hong Kong Limited
P2/3
BB
(67)
Pembrolizumab
Metastatic Pancreatic Cancer
Essen Biotech
P2/3
BB
(67)
PREDNISONE TABLETS
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P2/3
BB
(67)
Showing 101 to 125 of 1,537 assets
Previous
Page 5 of 62
Next